corporate governance clinical advisory board collaborations wilson disease wilson disease symptoms diagnosis treatment unmet needs life with wilson disease patient support decuprate decuprate clinical trials media & investors media & investors the share major shareholders financial reports ipo press releases news financial calendar subscribe media contact contact us contact us media contact committed to improving life with wilson disease committed to improving life with wilson disease committed to improving life with wilson disease 1 in 30 000 . that s approximately how many people worldwide who have wilson disease a rare genetic disorder that prevents the body from regulating copper and can lead to serious liver and brain damage . wilson disease is universally fatal if left undiagnosed and untreated . however a rare disease is only rare until you or someone you know is affected . at wilson therapeutics we are focused on improving the lives of patients with this serious disease through development of new treatment options and support for increased awareness and education . learn from the community watch a video about wilson disease featuring patients physicians and others affected by this rare genetic disease . press releases sep 21 2016 wilson therapeutics announces support of the annual event big wow to raise awareness of wilson disease aug 18 2016 wilson therapeutics ab publ interim report january 1 june 30 2016 aug 15 2016 wilson therapeutics appoints vincent metzler as vice president commercial planning & launch strategy press release archive financial calendar nov 25 2016 interim report for the third quarter 2016 nov 28 2016 stora aktiedagen stockholm jan 09 2017 j.p. morgan healthcare conference 2017 feb 23 2017 year end report 2016 may 17 2017 interim report for the first quarter 2017 all events wilson therapeutics uses software programs to analyze traffic to this website . these programs collect aggregate data . personal information is not collected . wilson therapeutics uses cookies on its websites but only to improve visitor experience and website performance . our cookies do not contain any personally identifiable information such as name or email address . i understand wilson therapeutics ab address v stra tr dg rdsgatan 15 se 111 53 stockholm sweden phone 46 8 796 00 00 registration number 556893 0357 privacy